CIK: 1437590 - Address: 66 Hudson Boulevard East, Attn: Corporate Secretary, New York, NY 10001-2192
25 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret116-0-110-460
S%wins1001005050753368

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/9/22 16:08
11/7/22
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d2,62733.2107923422D
5/12/22 16:34
5/11/22
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS.d-3,15249.320-64-16335D
3/4/22 16:13
3/3/22
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d3,26131.83010235398D
12/21/21 18:31
12/17/21
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d2,14830.1707125353D
11/15/21 17:40
11/11/21
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d5,01525.130200243282D
11/15/21 17:40
11/11/21
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS.d-3,00150.290-60-17282D
5/19/20 17:37
5/18/20
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-3,60337.780-95-35177D
3/5/19 16:54
3/1/19
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d3,32831.34010658291D
3/5/19 16:54
3/1/19
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS.dm-6,51343.550-150-34291D
2/1/19 19:28
1/31/19
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d3,75129.78012653364D
9/17/18 16:08
9/13/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d4,46224.560182335236D
3/12/18 17:01
3/9/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-2,55036.590-70-5753D
3/5/18 09:23
3/2/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-50135.850-14-10122D
3/2/18 15:24
2/28/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d5,42627.370198136D
2/28/18 18:04
2/27/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-2,39237.040-65-4097D
2/27/18 19:32
2/24/18
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d3,29018.900174117D
3/3/17 16:06
3/1/17
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS.m-1,06934.5133-31-3851D71919107310-1-1
3/1/17 17:10
2/27/17
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-2,01634.2633-59-4282D7190986100-10
2/27/17 18:21
2/23/17
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d4,59421.0333218142D6160106752010
5/5/16 17:29
5/4/16
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-2,26233.4633-68-15372D191-313112120047-6
2/26/16 15:05
2/24/16
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d3,97418.903321097428D3-9-1-12532-1-2-3131616
3/6/15 19:32
3/5/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-2,00934.4633-58-14357D31919106-10-10012-4-9
2/27/15 18:27
2/25/15
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DM.d2,59017.693314654416D3712201575011011-4-9
3/5/14 17:36
3/4/14
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-1,16632.5833-36-9346D66221846341-1-1-1-9-910
3/8/13 10:30
3/6/13
PFEPfizer IncDEHealthDrugPharmaceutical PreparationsDolsten MikaelNYOP R,DS-86028.1133-31-9306D5536211364520-130218

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact